---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-050025"
form_type: "8-K"
ticker: "BIXT"
cik: "0001445815"
company_name: "BIOXYTRAN, INC"
filed_at: "2026-11-05T02:38:11+00:00"
generated_at: "2026-11-05T11:05:38.730061+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Bioxytran secures attested Free Sale Certificate for A-SUQAR, targeting UAE and Gulf markets

## Summary
- A-SUQAR received a government-issued Free Sale Certificate, legalized by the issuing country's Ministry of Foreign Affairs and prepared for attestation for UAE use.
- Certificate confirms A-SUQAR is lawfully manufactured and freely sold as a food and health supplement; Bioxytran plans UAE product registration with its distribution partner.
- Bioxytran will evaluate registration pathways in Saudi Arabia, Kuwait and other GCC markets; launch timing depends on completion of local regulatory requirements.
- A-SUQAR is a pre-meal chewable tablet using polysaccharides to slow intestinal carbohydrate enzymes; it is regulated as a U.S. dietary supplement, not an FDA-approved drug.
- Release cites about 7.5M adults with diabetes across UAE, Saudi Arabia and Kuwait; UAE prevalence 20.7%, Saudi 23.1%, Kuwait 25.6% (IDF 2025).

## SEC filing metadata
- accession: 0001493152-26-050025
- form_type: 8-K
- ticker: BIXT
- cik: 0001445815
- company_name: BIOXYTRAN, INC
- filed_at: 2026-11-05T02:38:11+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1445815/000149315226050025/0001493152-26-050025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1445815/000149315226050025/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-050025
- JSON: https://secwatch.observer/filing/0001493152-26-050025.json
- Plain text: https://secwatch.observer/filing/0001493152-26-050025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.